Advances in breast cancer treatment have contributed to improved survival, but survivors experience significant cardiovascular mortality and morbid......READ MORE
Substantial progress has been made in the treatment of hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2-) br......READ MORE
Patients with advanced or metastatic hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2-) breast cancer who ha......READ MORE
Given the complexity of the management of breast cancer, it is increasingly important that multidisciplinary teams be involved to treat the whole p......READ MORE
Many patients with early and advanced breast cancer are living longer, and the impact of cancer treatment on longer-term cardiovascular health is p......READ MORE
The ovaries are the major source of estrogen in premenopausal women; therefore, ovarian suppression is required prior to the initiation of treatmen......READ MORE
